Indiana University Bloomington students are diving into the life sciences industry by learning about its complexities and intricate network of relationships that aid in bringing innovative health solutions to market. The IU Innovation and Commercialization Office is a sponsor of a course offered by the IU Kelley School of Business, “Life Sciences from Research to… Read more »
Entrepreneurship
IU researcher receives award to advance development of new therapeutic to combat HIV-1 latency
To advance faculty research and enhance the commercialization of Indiana University innovations, the IU Innovation and Commercialization Office has awarded the Lawrence Blatt Endowed Fund for Translational Research to Adarsh Dharan, an assistant professor of biology at IU Bloomington. The Lawrence Blatt Endowed Fund for Translational Research is designed to support the development of translational… Read more »
IU innovation, startup leaders set to shine at the “Oscars of Indiana Tech”
Just how much is Indiana University driving Indiana’s culture of innovation and entrepreneurship? Look no further than the list of nominees for the 2025 Mira Awards, honoring the best of tech in Indiana. TechPoint, Central Indiana Corporate Partnership’s industry-led growth initiative for Indiana’s digital innovation economy, recently announced more than a dozen IU-affiliated tech leaders… Read more »
IU celebrates opening of The Forge, Bloomington’s new tech center
Indiana University helped lead an all-out celebration “blitz” on Friday, Nov. 22, at the grand opening of The Forge, Bloomington’s new $13 million sustainable technology center in the city’s downtown Trades District. Even though IU’s football team suffered its first defeat the following day, Bloomington is still buzzing with excitement over two of its biggest… Read more »
IU microelectronics innovation to help fuel formation of new $285M national semiconductor institute
Indiana University will play a key role in the formation of a first-of-its-kind national institute targeting the next frontier of technological innovation in the microelectronics industry. IU is a member of the team that was selected this week by the National Institute for Standards and Technology to launch the new Semiconductor Manufacturing and Advanced Research… Read more »
IU-developed training for advance care planning helps nursing home facilities honor patients’ wishes
Anyone could be faced with unexpected medical conditions, unable to communicate their health care decisions, so it is important to have plans in place ahead of time to ensure a patient’s wishes are being honored—particularly in a nursing home setting. With the online training they developed specifically for nursing home staff, Susan Hickman and her… Read more »
IU researcher develops new nanoparticle to help combat drug-resistant infections
Antimicrobial resistance has become a major global public health emergency that accounts for 2.8 million infections per year according to the U.S. Centers for Disease Control and Prevention. Despite new and existing antibiotics on the market, the antimicrobial resistance is outpacing the development, making the need for new antimicrobial treatments a growing priority. Yan Yu,… Read more »
IU faculty startup MBX Biosciences announces $163.2 million U.S. IPO
MBX Biosciences, an Indiana University faculty-created startup that develops peptide therapies for the treatment of endocrine and metabolic diseases, raised $163.2 million in its U.S. initial public offering. The company’s peptides are based on chemistry developed by a research team led by Richard DiMarchi, scientific cofounder of MBX Biosciences and Distinguished Professor of Chemistry in… Read more »
Patents awarded to three IU health innovations
Three Indiana University-led research innovations, designed to improve the treatment of Alzheimer’s disease and ovarian and other cancers, recently received patents from the U.S. Patent and Trademark Office. Below is information about each patent. Patent issued to small molecule inhibitors of ALDH for the treatment of epithelial ovarian cancer: The U.S. Patent and Trademark Office… Read more »
IU researcher develops therapies for severe asthma
Asthma affects 8 percent of the U.S. population. Severe asthma—the symptoms of which are difficult to manage despite high doses of medicines, like corticosteroids—accounts for most healthcare costs due to its complexity to treat. New therapies are needed to eliminate symptoms of this life-threatening disease. Ben Gaston, the Billie Lou Wood Professor of Pediatrics at… Read more »